U.S. regulators have approved the first targeted drug for certain patients with an aggressive form of leukemia.
By The Associated Press, St. Louis Post-Dispatch: Business
Fri, 04/28/2017 - 1:13pm
U.S. regulators have approved the first targeted drug for certain patients with an aggressive form of leukemia.